Structured evidence table for Omega-3 Depression Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Omega-3 Depression Randomized Trial | Increasing evidence suggests that no single biomarker is likely to capture this complexity, and that integrative multi-omics approaches may provide a more clinically meaningful framework for precision psychiatry. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
| Omega-3 Depression Randomized Trial | The co-occurrence of these conditions increases symptom severity, the risk of relapse, and reduces the likelihood of full remission. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
| Omega-3 Depression Randomized Trial | This phenomenon is associated with an increased risk of hospitalization, suicide, and a marked rise in healthcare costs. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
| Omega-3 Depression Randomized Trial | 1 2 Recurrent major depressive disorder and depressive episode (MDD; ICD-10: F32–F33) as well as generalized anxiety disorder (GAD; ICD-10: F41.1) are among the most prevalent and most burdensome psychiatric entities on a global scale. | 3 | Kowalczyk Mateusz (2026) | Amino Acid–Fatty Acid Profile as a Novel Predictive Method in the Assessment of Diagnosis and Treatment Efficacy of Anxiety-Related Disorders and Mood Disorders |
| Omega-3 Depression Randomized Trial | A comprehensive review of psychiatric presentations reported that psychiatric symptoms span attention problems, anxiety, mood/behavioral disorders, and psychosis and identified > 100 IEMs associated with psychiatric manifestations; in a curated analysis, 94 IEMs were linked to psychiatric symptoms, with mood changes ranging from depressive syndromes to bipolar-like presentations []. | 3 | Hachmeriyan Antoniya (2026) | From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression |
| Omega-3 Depression Randomized Trial | 6 7 Clinically, mood disorders associated with IEMs often exhibit characteristic diagnostic patterns that may aid early recognition. | 3 | Hachmeriyan Antoniya (2026) | From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression |
| Omega-3 Depression Randomized Trial | When methylation capacity is constrained, through low folate/B12 status, reduced enzyme function (e.g., MTHFR variants), inflammation, oxidative stress, alcohol use, or high metabolic demand, homocysteine can rise, and SAMe availability can fall, creating a low methylation status that plausibly amplifies emotional volatility via neurotransmitter and epigenetic pathways []. | 3 | Hachmeriyan Antoniya (2026) | From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression |
| Omega-3 Depression Randomized Trial | 1 2 Depression and anxiety disorders are leading contributors to global disability. | 3 | Hachmeriyan Antoniya (2026) | From Plate to Mind: Scientific Perspectives on Foods That May Influence Anxiety and Depression |
Source documents